Home / Care Tools / Articles / Care Tools Articles

Care Tools Articles

A recent study corroborated increased susceptibility to cancer in DM1, for women in particular, and linked the elevated risk to depressed levels of a tumor suppressor microRNA (miRNA). 

Many common DM symptoms become more severe during pregnancy, and women with DM have higher than average miscarriage rates, according to a study commissioned by MDF that examined data from the Myotonic Dystrophy Family Registry and the National Registry for DM and FSHD. Read a summary of the findings written by Katharine Hagerman, PhD, Research Assistant at Stanford University.

New research on the impact of the mother's age on congenitally affected offspring.

Researchers have published several recent studies on advances in DM research.

Partners

© Myotonic Dystrophy Foundation. All rights reserved.